AstraZeneca AZN Balance Sheet

Income Statement

Quarter End	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	100.27B	96.58B	94.19B	96.48B	96.69B	96.54B	96.09B	101.12B
Total Current Assets	22.65B	20.92B	20.22B	22.59B	22.27B	22.84B	22.5B	25.05B
Cash and Equivalents	5.76B	4.82B	4.46B	6.17B	6.23B	5.66B	4.87B	5.84B
Total Non-Current Assets	76.67B	83.48B	73.09B	81.46B	82.11B	81.43B	72.61B	84.37B
Total Liabilities	63.91B	60.63B	59.03B	59.43B	60.88B	59.13B	58.87B	61.95B
Total Current Liabilities	22.74B	21.82B	24.85B	26.29B	24.86B	26.38B	28.59B	30.54B
Total Non-Current Liabilities	69.98B	65.96B	57.86B	56.82B	63.66B	57.8B	53.25B	54.63B
Common Equity	387M	387M	387M	387M	387M	387M	387M	388M
Retained Earnings	-1.23B	-1.66B	-2.47B	-574M	-1.83B	-234M	-434M	1.5B

Year End December 30 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	62.53B	63.35B	60.65B	61.38B	66.73B	105.36B	96.48B	101.12B
Total Current Assets	13.26B	13.15B	15.59B	15.56B	19.54B	26.24B	22.59B	25.05B
Cash and Equivalents	5.02B	3.32B	4.83B	5.37B	7.83B	6.33B	6.17B	5.84B
Total Non-Current Assets	16.67B	16.64B	14.04B	14.6B	15.64B	39.29B	37.06B	39.17B
Total Liabilities	45.86B	46.71B	46.61B	46.78B	51.09B	66.08B	59.43B	61.95B
Total Current Liabilities	15.26B	16.38B	16.29B	18.12B	20.31B	22.59B	26.29B	30.54B
Total Non-Current Liabilities	45.1B	45.89B	47.67B	44.88B	48.78B	72.37B	56.82B	54.63B
Total Equity	16.67B	16.64B	14.04B	14.6B	15.64B	39.29B	37.06B	39.17B
Common Equity	316M	317M	317M	328M	328M	387M	387M	388M
Retained Earnings	8.14B	8.22B	5.68B	2.81B	5.3B	1.71B	-574M	1.5B